News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
212,658 Results
Type
Article (13571)
Company Profile (65)
Press Release (199013)
Multimedia
Podcasts (15)
Webinars (3)
Section
Business (51383)
Career Advice (915)
Deals (8084)
Drug Delivery (18)
Drug Development (48177)
Employer Resources (60)
FDA (4903)
Job Trends (5080)
News (109052)
Policy (8246)
Tag
2027 Biotech Bay Standard (2)
Academia (1121)
Accelerated approval (15)
Adcomms (7)
Allergies (99)
Alliances (16479)
ALS (79)
Alzheimer's disease (821)
Antibody-drug conjugate (ADC) (147)
Approvals (5122)
Artificial intelligence (180)
Autoimmune disease (131)
Automation (13)
Bankruptcy (30)
Best Places to Work (4716)
BIOSECURE Act (1)
Biosimilars (67)
Biotechnology (53)
Bladder cancer (117)
Brain cancer (40)
Breast cancer (354)
Cancer (3106)
Cardiovascular disease (138)
Career advice (769)
Career pathing (15)
CAR-T (199)
CDC (45)
Cell therapy (466)
Cervical cancer (21)
Clinical research (42992)
Collaboration (750)
Compensation (146)
Complete response letters (16)
COVID-19 (1785)
CRISPR (43)
C-suite (266)
Cystic fibrosis (82)
Data (4191)
Decentralized trials (1)
Denatured (4)
Depression (70)
Diabetes (233)
Diagnostics (1797)
Digital health (13)
Diversity (2)
Diversity, equity & inclusion (18)
Drug discovery (95)
Drug pricing (23)
Drug shortages (5)
Duchenne muscular dystrophy (111)
Earnings (20132)
Editorial (12)
Employer branding (7)
Employer resources (52)
Events (32502)
Executive appointments (284)
FDA (6319)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (11)
Funding (602)
Gene editing (84)
Generative AI (15)
Gene therapy (292)
GLP-1 (387)
Government (1642)
Grass and pollen (4)
Guidances (143)
Healthcare (7089)
HIV (42)
Huntington's disease (20)
IgA nephropathy (58)
Immunology and inflammation (181)
Immuno-oncology (41)
Indications (56)
Infectious disease (1967)
Inflammatory bowel disease (125)
Influenza (79)
Intellectual property (95)
Interviews (140)
IPO (3895)
IRA (6)
Job creations (610)
Job search strategy (704)
JPM (10)
Kidney cancer (12)
Labor market (14)
Layoffs (135)
Leadership (7)
Legal (824)
Liver cancer (45)
Longevity (2)
Lung cancer (437)
Lymphoma (285)
Machine learning (14)
Management (16)
Manufacturing (270)
MASH (74)
Medical device (1907)
Medtech (1923)
Mergers & acquisitions (4589)
Metabolic disorders (582)
Multiple sclerosis (118)
NASH (4)
Neurodegenerative disease (137)
Neuropsychiatric disorders (41)
Neuroscience (1487)
NextGen: Class of 2026 (2172)
Non-profit (1755)
Now hiring (2)
Obesity (260)
Opinion (82)
Ovarian cancer (132)
Pain (75)
Pancreatic cancer (154)
Parkinson's disease (176)
Partnered (10)
Patents (165)
Patient recruitment (310)
Peanut (53)
People (13931)
Pharmaceutical (8)
Pharmacy benefit managers (7)
Phase 1 (15866)
Phase 2 (19675)
Phase 3 (12041)
Pipeline (2791)
Policy (73)
Postmarket research (933)
Preclinical (4540)
Press Release (17)
Prostate cancer (139)
Psychedelics (14)
Radiopharmaceuticals (111)
Rare diseases (404)
Real estate (1339)
Recruiting (24)
Regulatory (7768)
Reports (11)
Research institute (1256)
Resumes & cover letters (139)
Rett syndrome (21)
RNA editing (2)
RSV (68)
Schizophrenia (92)
Series A (114)
Series B (76)
Service/supplier (2)
Sickle cell disease (41)
Special edition (2)
Spinal muscular atrophy (77)
Sponsored (21)
Startups (1124)
State (1)
Stomach cancer (12)
Supply chain (31)
Tariffs (15)
The Weekly (11)
Vaccines (800)
Venture capital (23)
Weight loss (155)
Women's health (22)
Worklife (4)
Date
Today (27)
Last 7 days (233)
Last 30 days (856)
Last 365 days (13148)
2026 (1236)
2025 (13224)
2024 (14415)
2023 (16103)
2022 (19621)
2021 (20549)
2020 (19236)
2019 (15584)
2018 (11855)
2017 (10406)
2016 (9118)
2015 (10427)
2014 (6922)
2013 (5305)
2012 (5539)
2011 (5848)
2010 (4836)
Location
Africa (261)
Alabama (35)
Alaska (3)
Arizona (67)
Arkansas (4)
Asia (14845)
Australia (2536)
California (4751)
Canada (1217)
China (611)
Colorado (181)
Connecticut (199)
Delaware (183)
Europe (32333)
Florida (709)
Georgia (132)
Hawaii (2)
Idaho (23)
Illinois (298)
India (27)
Indiana (233)
Iowa (12)
Japan (210)
Kansas (32)
Kentucky (19)
Louisiana (8)
Maine (56)
Maryland (545)
Massachusetts (3584)
Michigan (70)
Minnesota (99)
Mississippi (2)
Missouri (33)
Montana (18)
Nebraska (7)
Nevada (54)
New Hampshire (15)
New Jersey (1353)
New Mexico (7)
New York (1392)
North Carolina (441)
North Dakota (1)
Northern California (2405)
Ohio (95)
Oklahoma (4)
Oregon (15)
Pennsylvania (949)
Puerto Rico (4)
Rhode Island (21)
South America (375)
South Carolina (6)
South Dakota (1)
Southern California (1794)
Tennessee (46)
Texas (775)
United States (16551)
Utah (83)
Virginia (142)
Washington D.C. (25)
Washington State (500)
West Virginia (3)
Wisconsin (31)
212,658 Results for "immune tolerance network".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Repertoire® Immune Medicines Announces Strategic Collaboration with Lilly to Develop Tolerizing Therapies for Autoimmune Diseases
January 29, 2026
·
2 min read
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Osel Enters Agreement with SWOG Cancer Research Network for First-Ever Pivotal Trial of a Microbiome-Based Therapy in Oncology
January 8, 2026
·
4 min read
Press Releases
MicroTransponder Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
January 19, 2026
·
3 min read
Press Releases
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
January 27, 2026
·
3 min read
Press Releases
ACG Packaging Materials Joins World Economic Forum’s Global Lighthouse Network as World’s First Pharmaceutical Packaging Company
February 5, 2026
·
1 min read
Press Releases
Phase 1 Clinical Ttrial of HIV Vaccine Starts in Africa to Evaluate Immune Responses to Highly Networked HIV T-Cell Epitopes
August 5, 2025
·
5 min read
Press Releases
Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.
January 29, 2026
·
7 min read
Press Releases
ALS Network and ALS United Announce New Research Grantees
November 21, 2025
·
5 min read
Press Releases
TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network
Initial shipment delivered to distributor warehouse supports expansion into B2B pharmacy distribution alongside direct-to-consumer activities
January 6, 2026
·
5 min read
1 of 21,266
Next
